- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04540081
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer (CLOVER)
December 23, 2023 updated by: University of California, Davis
The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- UC Davis Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.
Exclusion Criteria:
- Patients outside of the age limits or have an established PCP.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CLOVER arm
This arm will contain clinics that utilize the CLOVER intervention
|
Electronic population health module which is tailored to increased adherence to USPSTF and CDC recommendations
|
|
No Intervention: Standard of Care arm
This arm will contain clinics that do not utilize the CLOVER intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Adherence to CLOVER Metrics
Time Frame: 6 months
|
This is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Colon cancer screening
Time Frame: 6 months
|
Proportion of eligible patients who completed colon cancer screening.
|
6 months
|
|
Lung cancer screening
Time Frame: 6 months
|
Proportion of eligible patients who completed lung cancer screening.
|
6 months
|
|
Tobacco cessation counseling
Time Frame: 6 months
|
Proportion of eligible patients who completed tobacco cessation counseling.
|
6 months
|
|
Obesity counseling
Time Frame: 6 months
|
Proportion of eligible patients who completed obesity counseling.
|
6 months
|
|
Pneumonia vaccination
Time Frame: 6 months
|
Proportion of eligible patients who completed pneumonia vaccination.
|
6 months
|
|
Shingles vaccination
Time Frame: 6 months
|
Proportion of eligible patients who completed shingles vaccination.
|
6 months
|
|
Hepatitis C screening
Time Frame: 6 months
|
Proportion of eligible patients who completed hepatitis C screening.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 5, 2020
Primary Completion (Actual)
October 5, 2022
Study Completion (Actual)
October 5, 2022
Study Registration Dates
First Submitted
August 31, 2020
First Submitted That Met QC Criteria
August 31, 2020
First Posted (Actual)
September 7, 2020
Study Record Updates
Last Update Posted (Actual)
December 27, 2023
Last Update Submitted That Met QC Criteria
December 23, 2023
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Blood-Borne Infections
- Communicable Diseases
- Neoplasms
- Pneumonia
- Lung Diseases
- Neoplasms by Site
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Liver Diseases
- Overnutrition
- Nutrition Disorders
- Overweight
- Body Weight
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Flaviviridae Infections
- Colonic Diseases
- Intestinal Diseases
- Hepatitis, Viral, Human
- Bacterial Infections
- Bacterial Infections and Mycoses
- Intestinal Neoplasms
- Colorectal Neoplasms
- Hepatitis
- Obesity
- Lung Neoplasms
- Hepatitis C
- Liver Neoplasms
- Pneumonia, Bacterial
- Colonic Neoplasms
Other Study ID Numbers
- 1624888
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Epic Healthy Planet Population Health Module
-
Northern Arizona UniversityNational Institute of Dental and Craniofacial Research (NIDCR)TerminatedDental Caries | Early Childhood CariesUnited States
-
Washington University School of MedicineWithdrawnProstate Cancer | Prostatectomy